Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

SAB4502829

Sigma-Aldrich

Anti-α-Synuclein (SNCA) Antibody

rabbit polyclonal

Synonym(s):

α-synuclein, NACP, Non-A β component of AD amyloid, Non-A4 component of amyloid precursor, SNCA

Sign Into View Organizational & Contract Pricing

Select a Size

100 μG
$522.00

$522.00

Usually ships in 5 business days. (Orders outside of US, please allow an additional 1-2 weeks for delivery)
A recombinant, preservative-free antibody is available for your target. Try ZRB1134
All Photos(1)

Select a Size

Change View
100 μG
$522.00

About This Item

MDL number:
MFCD02095740
UNSPSC Code:
12352203
NACRES:
NA.41

$522.00

Usually ships in 5 business days. (Orders outside of US, please allow an additional 1-2 weeks for delivery)
A recombinant, preservative-free antibody is available for your target. Try ZRB1134

Product Name

Anti-Synuclein-α antibody produced in rabbit, affinity isolated antibody

biological source

rabbit

Quality Level

100

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen 14 kDa

species reactivity

mouse, rat, human

concentration

~1 mg/mL

technique(s)

ELISA: 1:40000
western blot: 1:500-1:1000

NCBI accession no.

P37840

UniProt accession no.

P37840

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... SNCA(6622)

General description

Anti-Synuclein-α antibody detects endogenous levels of total Synuclein-α protein.
The SNCA (synuclein α) gene is mapped to human chromosome 4q22.1.

Immunogen

The antiserum was produced against synthesized peptide derived from human Synuclein-alpha.

Immunogen Range: 86-135

Biochem/physiol Actions

Accumulation of α-synuclein in oligodendrocytes results in the loss of myelin and causes neurodegeneration, leading to multiple system atrophy. Synuclein-α is known to induce oligodendrocyte maturation. The encoded protein is considered to be an important aggregate of Lewy bodies, contributing to the pathogenesis of Parkinson disease.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physical form

Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk_germany

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
217234

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jian-Feng Li et al.
Foods (Basel, Switzerland), 13(9) (2024-05-11)
Parkinson's disease (PD), the second most common neurodegenerative disorder, is linked to α-synuclein (α-Syn) aggregation. Despite no specific drug being available for its treatment, curcumin, from the spice turmeric, shows promise. However, its application in PD is limited by a
SNCA variants are associated with increased risk for multiple system atrophy.
Scholz SW
Annals of Neurology, 65(5), 610-614 (2009)
Synucleins Have Multiple Effects on Presynaptic Architecture.
Vargas KJ
Cell Reports, 18(1), 161-173 (2017)
?-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
Ettle B
Acta Neuropathologica, 132(1), 59-75 (2016)

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service